|
 |
 Dr.
Mervyn Jacobson
Chief Executive Officer and President, XY Inc.
Chairman, Board of Directors, XY Inc.
jacobsonm@xyinc.com
Dr. Mervyn Jacobson, M.B.B.S., is Chairman of the Board of Directors
of XY Inc. and also XY's CEO and President. Dr. Jacobson, a graduate
of the University of Melbourne Medical School, is recognized worldwide
as a leader in developing new technology-based businesses in the
fields of biotechnology and advanced genetics - with special relevance
to
medical and veterinarian applications. His successful commercial,
medically related ventures include:
- formation
of the Regional Medical Supply Company, which grew to become
one of Australia's largest importers and distributors of medical,
dental and hospital supplies;
- founder
of Datalab, a sophisticated diagnostic laboratory in Australia,
which grew to become a highly profitable business, and was
sold in 1993.
Dr.
Jacobson, who is a consultant to the University of Zurich's
Research for the Horse program and a sought-after speaker
for major
international scientific gatherings, also is Chairman of GeneType AG, a
Swiss-based genetic research company that specializes in advanced
DNA
genetic
research and testing. Genetype's main research and development
facility currently is in Australia. In 1998, the Australian government
awarded GeneType a multi-million dollar grant to encourage expansion of
its
advanced DNA research in Australia.
In August 2000, GeneType AG was acquired by Genetic Technologies
Limited (GTG). Dr. Jacobson then was appointed Executive
Chairman of GTG,
a public company on the Australian Stock Exchange.
In 2004, Dr. Jacobson was appointed Chief Technology Officer
of the Scientific Advisory Board of the Chinese National
Animal Breeding
Stock Export/Import Corporation.
 Dr. David Cran
dcran@xyinc.com
Dr. Cran, Scientist, XY Inc., earned his Ph.D. from Edinburgh University in
Scotland. After a four year postdoctoral position in Australia he joined
the Animal Research Station in Cambridge, known for its extensive
pioneering work in animal reproduction. During the next 17 years at
Cambridge and at the Babraham Institute, Cran carried out basic studies on
the physiology and structure of eggs and spermatozoa, and was involved in
the elucidation of the nature of cellular signals during fertilization.
He also was involved in early studies into IVF in pigs and sheep and has
published numerous scientific articles. In late 1991 Cran joined Mastercalf
Ltd., also located in Cambridge, and was responsible for the project that
produced the first sex-selected calves in 1992. In 1995 the center for
semen sexing moved to Aberdeen where a collaboration with the Scottish
Agricultural College resulted in the first lambs to be born following
intrauterine insemination with sexed sperm. After XY Inc. acquired
Mastercalf Ltd. in 1997, Dr Cran assumed a dual assignment in the UK and
Colorado. Today he is supporting the XY Inc. research program and training
new licensees about the XY technology.
 John
L. Schenk
jschenk@xyinc.com
John Schenk, Manager, XY Inc., grew up on a large Colorado farm and has spent his
entire career in the field of cattle physiology and reproduction. Schenk
holds a bachelor's degree in bio-agricultural science as well as a master's
degree in reproductive physiology from Colorado State University. His
experience includes nearly eight years as a reproductive physiologist for
ABS Global, a major bull stud operation and four years in production with
other bull-stud operations. Through his years in the bull-stud industry,
he has made contacts with many companies that likely will become licensees
of XY Inc.'s technology.
Thom
Gilligan
Manager
Thom
Gilligan received a B.A. degree in biology
from the University of
California, Santa Cruz
in 1985. From 1985-1987
he did routine laboratory
ork in clinical diagnostics.
From 1987 to 1993 he held
various positions in
research related to recombinant
DNA techniques, enzymatic
catalyis for
organic synthesis, microbial
screening, fermentation
and bioprocess scale-up
at Lonza Biotec in Switzerland.
In 1990, he spent a year
as a guest
researcher at Kyoto University
in the laboratory of Professor
Hideaki
Yamada, working on a new
biocatalysis method for
production of nicotinamide.
In 1994, he returned to
the United States where
he initiated the commercial
development activities
for Lonza Biotec, with
emphasis on technology
collaborations in drug
synthesis using new bioprocessing
methods. Thom
joined XY Inc. in August
of 2002, after having
spent two years at Proligo
in
Boulder, Colorado as Director
of Business Development,
where he helped
establish Proligo (subsidiary
of Degussa, Germany) as
a leading supplier to
the genetics and genomics
industry.
Thom's
experience in larger
organizations that
successfully scaled up
and
introduced new profitable
production and processing
technologies, as well
as
his complementary knowledge
in technical as well as business
success factors for
advancements of
new
technologies, are important
assets in facilitating
the growth of XY Inc.
The international nature
of the XY Inc. opportunity
is also well-suited to
Thom's crosscultural experience
in Europe and Japan.
Todd Cox
Instrumentation Specialist
Todd
Cox, Instrumentation Specialist,
XY Inc.,
brings almost 20 years
of technical operations
and engineering experience
to his XY position. He
has full-scale knowledge
and application of electrical
systems, components and
related products and support
and is an expert troubleshooter
of technical systems and
processes. Over his career
within the
electronics
industry Cox has served
as inventor, market specialist,
system specialist and
customer support technician.
For a number of years
he owned and operated
a computer-support company.
Currently, Cox provides
all aspects of instrumentation
support for XY Inc. and
its global licensees and
research partners.
Kathy Means
Trainer
Kathy
Means provides on-site
training support
to all XY Inc.
licensees. She graduated
from Colorado
State University with
a bachelor’s degree
in biology and joined
XY Inc. as a senior
laboratory
technician
and MoFlo operator.
She is an avid researcher
in the cutting-edge
field of sex-selection
in
animals,
and she has a particular interest
in preserving exotic
and endangered
species.
|
|
